Further analysis of the Oncomine database showed that CBX8 was highly expressed in colorectal cancer, leukemia, liver cancer, lung cancer and sarcoma (Supplementary Figure 4, all P-values < 0.05) compared with normal controls. Here, CBX8 is linked to lung carcinoma.